213 related articles for article (PubMed ID: 21826227)
41. Hepatocyte Growth Factor Attenuates the Development of TGF-β1- Induced EndMT through Down-regulating the Notch Signaling.
Yang R; Yang F; Hu Y; Chen M; Liu Y; Li J; Zhong W
Endocr Metab Immune Disord Drug Targets; 2020; 20(5):781-787. PubMed ID: 31702496
[TBL] [Abstract][Full Text] [Related]
42. Knockdown of vascular cell adhesion molecule 1 impedes transforming growth factor beta 1-mediated proliferation, migration, and invasion of endometriotic cyst stromal cells.
Zhang J; Li H; Yi D; Lai C; Wang H; Zou W; Cao B
Reprod Biol Endocrinol; 2019 Aug; 17(1):69. PubMed ID: 31443713
[TBL] [Abstract][Full Text] [Related]
43. SB-431542, a small molecule transforming growth factor-beta-receptor antagonist, inhibits human glioma cell line proliferation and motility.
Hjelmeland MD; Hjelmeland AB; Sathornsumetee S; Reese ED; Herbstreith MH; Laping NJ; Friedman HS; Bigner DD; Wang XF; Rich JN
Mol Cancer Ther; 2004 Jun; 3(6):737-45. PubMed ID: 15210860
[TBL] [Abstract][Full Text] [Related]
44. Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.
Ganapathy V; Ge R; Grazioli A; Xie W; Banach-Petrosky W; Kang Y; Lonning S; McPherson J; Yingling JM; Biswas S; Mundy GR; Reiss M
Mol Cancer; 2010 May; 9():122. PubMed ID: 20504320
[TBL] [Abstract][Full Text] [Related]
45. Notch and TGF-β pathways cooperatively regulate receptor protein tyrosine phosphatase-κ (PTPRK) gene expression in human primary keratinocytes.
Xu Y; Xue S; Zhou J; Voorhees JJ; Fisher GJ
Mol Biol Cell; 2015 Mar; 26(6):1199-206. PubMed ID: 25609089
[TBL] [Abstract][Full Text] [Related]
46. Structure Identification of ViceninII Extracted from
Luo Y; Ren Z; Du B; Xing S; Huang S; Li Y; Lei Z; Li D; Chen H; Huang Y; Wei G
Molecules; 2019 Jan; 24(1):. PubMed ID: 30609689
[TBL] [Abstract][Full Text] [Related]
47. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling.
Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067
[TBL] [Abstract][Full Text] [Related]
48. Activation of the ALK-5 Pathway is not per se Sufficient for the Antiproliferative Effect of TGF-β1 on Renal Tubule Epithelial Cells.
García-Sánchez O; Sancho-Martínez SM; López-Novoa JM; López-Hernández FJ
Cell Physiol Biochem; 2015; 37(4):1231-9. PubMed ID: 26431052
[TBL] [Abstract][Full Text] [Related]
49. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
[TBL] [Abstract][Full Text] [Related]
50. Requirement of HDAC6 for activation of Notch1 by TGF-β1.
Deskin B; Lasky J; Zhuang Y; Shan B
Sci Rep; 2016 Aug; 6():31086. PubMed ID: 27499032
[TBL] [Abstract][Full Text] [Related]
51. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.
Halder SK; Beauchamp RD; Datta PK
Neoplasia; 2005 May; 7(5):509-21. PubMed ID: 15967103
[TBL] [Abstract][Full Text] [Related]
52. Transforming growth factor: beta signaling is essential for limb regeneration in axolotls.
Lévesque M; Gatien S; Finnson K; Desmeules S; Villiard E; Pilote M; Philip A; Roy S
PLoS One; 2007 Nov; 2(11):e1227. PubMed ID: 18043735
[TBL] [Abstract][Full Text] [Related]
53. The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer.
Yamamura S; Matsumura N; Mandai M; Huang Z; Oura T; Baba T; Hamanishi J; Yamaguchi K; Kang HS; Okamoto T; Abiko K; Mori S; Murphy SK; Konishi I
Int J Cancer; 2012 Jan; 130(1):20-8. PubMed ID: 21503873
[TBL] [Abstract][Full Text] [Related]
54. Invasion and metastasis of a mammary tumor involves TGF-beta signaling.
McEarchern JA; Kobie JJ; Mack V; Wu RS; Meade-Tollin L; Arteaga CL; Dumont N; Besselsen D; Seftor E; Hendrix MJ; Katsanis E; Akporiaye ET
Int J Cancer; 2001 Jan; 91(1):76-82. PubMed ID: 11149423
[TBL] [Abstract][Full Text] [Related]
55. TGF-β1 as possible link between loss of bone mineral density and chronic inflammation.
Ehnert S; Baur J; Schmitt A; Neumaier M; Lucke M; Dooley S; Vester H; Wildemann B; Stöckle U; Nussler AK
PLoS One; 2010 Nov; 5(11):e14073. PubMed ID: 21124921
[TBL] [Abstract][Full Text] [Related]
56. Involvement of transforming growth factor beta 1 in the transcriptional regulation of nicotinamide N-methyltransferase in clear cell renal cell carcinoma.
Campagna R; Cecati M; Pozzi V; Fumarola S; Pompei V; Milanese G; Galosi AB; Sartini D; Emanuelli M
Cell Mol Biol (Noisy-le-grand); 2018 May; 64(7):51-55. PubMed ID: 29974846
[TBL] [Abstract][Full Text] [Related]
57. Notch signaling mediates TGF-β1-induced epithelial-mesenchymal transition through the induction of Snai1.
Matsuno Y; Coelho AL; Jarai G; Westwick J; Hogaboam CM
Int J Biochem Cell Biol; 2012 May; 44(5):776-89. PubMed ID: 22330899
[TBL] [Abstract][Full Text] [Related]
58. Notch signaling inhibits cardiac fibroblast to myofibroblast transformation by antagonizing TGF-β1/Smad3 signaling.
Zhou XL; Fang YH; Wan L; Xu QR; Huang H; Zhu RR; Wu QC; Liu JC
J Cell Physiol; 2019 Jun; 234(6):8834-8845. PubMed ID: 30317638
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells.
Genz B; Coleman MA; Irvine KM; Kutasovic JR; Miranda M; Gratte FD; Tirnitz-Parker JEE; Olynyk JK; Calvopina DA; Weis A; Cloonan N; Robinson H; Hill MM; Al-Ejeh F; Ramm GA
Sci Rep; 2019 Jun; 9(1):8541. PubMed ID: 31189969
[TBL] [Abstract][Full Text] [Related]
60. TGF-β1 inhibits human trophoblast cell invasion by upregulating cyclooxygenase-2.
Yi Y; Cheng JC; Klausen C; Leung PCK
Placenta; 2018 Aug; 68():44-51. PubMed ID: 30055669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
